Published in J Biol Chem on July 10, 1998
No hypothermic response to serotonin in 5-HT7 receptor knockout mice. Proc Natl Acad Sci U S A (2003) 1.20
Serotonin 5-HT7 receptor agents: Structure-activity relationships and potential therapeutic applications in central nervous system disorders. Pharmacol Ther (2010) 1.05
The serotonin 5-HT7 receptors: two decades of research. Exp Brain Res (2013) 1.01
[3H]-Mesulergine labels 5-HT7 sites in rat brain and guinea-pig ileum but not rat jejunum. Br J Pharmacol (1999) 0.91
Serotonin suppresses the slow afterhyperpolarization in rat intralaminar and midline thalamic neurones by activating 5-HT(7) receptors. J Physiol (2002) 0.88
Luminal 5-HT stimulates colonic bicarbonate secretion in rats. Br J Pharmacol (2015) 0.83
Cellular mechanisms of the 5-HT7 receptor-mediated signaling. Front Behav Neurosci (2014) 0.82
The novel antipsychotic drug lurasidone enhances N-methyl-D-aspartate receptor-mediated synaptic responses. Mol Pharmacol (2011) 0.82
Antagonist interaction with the human 5-HT(7) receptor mediates the rapid and potent inhibition of non-G-protein-stimulated adenylate cyclase activity: a novel GPCR effect. Br J Pharmacol (2011) 0.79
Evolutionary conservation of the signaling proteins upstream of cyclic AMP-dependent kinase and protein kinase C in gastropod mollusks. Brain Behav Evol (2009) 0.79
How much do we know about the coupling of G-proteins to serotonin receptors? Mol Brain (2014) 0.78
Luciferase reporter gene assay on human 5-HT receptor: which response element should be chosen? Sci Rep (2015) 0.75
Polymyxin and related peptide antibiotics. Annu Rev Biochem (1977) 4.53
Stimulation of cAMP response element (CRE)-mediated transcription during contextual learning. Nat Neurosci (1998) 3.33
Ca2+/calmodulin binds to and modulates P/Q-type calcium channels. Nature (1999) 3.24
Cross talk between ERK and PKA is required for Ca2+ stimulation of CREB-dependent transcription and ERK nuclear translocation. Neuron (1998) 3.08
Calcium-stimulated adenylyl cyclase activity is critical for hippocampus-dependent long-term memory and late phase LTP. Neuron (1999) 2.86
Disruption of the type III adenylyl cyclase gene leads to peripheral and behavioral anosmia in transgenic mice. Neuron (2000) 2.73
Mapping of a gene for type 2 diabetes associated with an insulin secretion defect by a genome scan in Finnish families. Nat Genet (1996) 2.48
Induction of CRE-mediated gene expression by stimuli that generate long-lasting LTP in area CA1 of the hippocampus. Neuron (1996) 2.47
Presynaptic and postsynaptic actions and modulation of neuroendocrine neurons by a new hypothalamic peptide, hypocretin/orexin. J Neurosci (1998) 2.45
Vav is a regulator of cytoskeletal reorganization mediated by the T-cell receptor. Curr Biol (1998) 2.26
Light and circadian rhythmicity regulate MAP kinase activation in the suprachiasmatic nuclei. Nat Neurosci (1998) 2.20
Making new connections: role of ERK/MAP kinase signaling in neuronal plasticity. Neuron (1999) 2.17
Chromosome 1 loci in Finnish schizophrenia families. Hum Mol Genet (2001) 1.95
Altered behavior and long-term potentiation in type I adenylyl cyclase mutant mice. Proc Natl Acad Sci U S A (1995) 1.94
Compensation between Vav-1 and Vav-2 in B cell development and antigen receptor signaling. Nat Immunol (2001) 1.93
Constitutive μ-opioid receptor activity leads to long-term endogenous analgesia and dependence. Science (2013) 1.91
cAMP response element-mediated gene transcription is upregulated by chronic antidepressant treatment. J Neurosci (2000) 1.86
Circadian regulation of cAMP response element-mediated gene expression in the suprachiasmatic nuclei. J Biol Chem (1999) 1.85
Calcium-induced exposure of a hydrophobic surface on calmodulin. Biochemistry (1980) 1.85
Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype. J Biol Chem (1993) 1.84
Randomized phase 2b trial of tofacitinib (CP-690,550) in de novo kidney transplant patients: efficacy, renal function and safety at 1 year. Am J Transplant (2012) 1.79
Altered stress-induced anxiety in adenylyl cyclase type VIII-deficient mice. J Neurosci (2000) 1.65
Phosphorylation and inhibition of olfactory adenylyl cyclase by CaM kinase II in Neurons: a mechanism for attenuation of olfactory signals. Neuron (1998) 1.63
SRF-dependent gene expression is required for PI3-kinase-regulated cell proliferation. EMBO J (2000) 1.62
Disruption of the Escherichia coli outer membrane permeability barrier by immobilized polymyxin B. J Antibiot (Tokyo) (1977) 1.62
Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs. Mol Pharmacol (1993) 1.59
Fixed drug combinations and the displacement of bilirubin from albumin. Pediatrics (1971) 1.54
Primary structure and functional characterization of a human 5-HT1D-type serotonin receptor. Mol Pharmacol (1991) 1.52
Complex formation between bacitracin peptides and isoprenyl pyrophosphates. The specificity of lipid-peptide interactions. J Biol Chem (1973) 1.51
Resolution of adenylate cyclase sensitive and insensitive to Ca2+ and calcium-dependent regulatory protein (CDR) by CDR-sepharose affinity chromatography. Proc Natl Acad Sci U S A (1979) 1.46
Capacitative Ca2+ entry is involved in cAMP synthesis in mouse parotid acini. Am J Physiol (1998) 1.45
Inhibition of Escherichia coli growth and respiration by polymyxin B covalently attached to agarose beads. Biochemistry (1977) 1.45
A problem encapsulated: the rare peritoneal encapsulation syndrome. Singapore Med J (2006) 1.44
Type I adenylyl cyclase mutant mice have impaired mossy fiber long-term potentiation. J Neurosci (1998) 1.43
Characterization of the calmodulin binding domain of neuromodulin. Functional significance of serine 41 and phenylalanine 42. J Biol Chem (1991) 1.41
Altered expression of C/EBP family members results in decreased adipogenesis with aging. Am J Physiol Regul Integr Comp Physiol (2001) 1.40
Regulation of calmodulin binding to P-57. A neurospecific calmodulin binding protein. J Biol Chem (1987) 1.40
Identification and characterization of the calmodulin-binding domain of neuromodulin, a neurospecific calmodulin-binding protein. J Biol Chem (1988) 1.39
Hippocampal neurotoxicity of Delta9-tetrahydrocannabinol. J Neurosci (1998) 1.39
Excitatory actions of GABA after neuronal trauma. J Neurosci (1996) 1.38
Potent and selective nonpeptide inhibitors of caspases 3 and 7 inhibit apoptosis and maintain cell functionality. J Biol Chem (2000) 1.34
CRE-mediated gene transcription in neocortical neuronal plasticity during the developmental critical period. Neuron (1999) 1.34
The classification of dopamine receptors: relationship to radioligand binding. Annu Rev Neurosci (1983) 1.32
Sexual dimorphism in diverse metazoans is regulated by a novel class of intertwined zinc fingers. Genes Dev (2000) 1.31
Calcium binding to complexes of calmodulin and calmodulin binding proteins. Biochemistry (1985) 1.27
Cross-linking of iodine-125-labeled, calcium-dependent regulatory protein to the Ca2+-sensitive phosphodiesterase purified from bovine heart. Biochemistry (1979) 1.27
Cloning, characterization, and chromosomal localization of a human 5-HT6 serotonin receptor. J Neurochem (1996) 1.26
Quantitation of energy coupling between Ca2+, calmodulin, skeletal muscle myosin light chain kinase, and kinase substrates. J Biol Chem (1984) 1.26
Loss of adenylyl cyclase I activity disrupts patterning of mouse somatosensory cortex. Nat Genet (1998) 1.25
Central role for sodium in the pathogenesis of blood pressure changes independent of angiotensin, aldosterone and catecholamines in type 1 (insulin-dependent) diabetes mellitus. Diabetologia (1987) 1.25
Ca2+ inhibition of type III adenylyl cyclase in vivo. J Biol Chem (1995) 1.23
Distribution of mRNA for the calmodulin-sensitive adenylate cyclase in rat brain: expression in areas associated with learning and memory. Neuron (1991) 1.21
Missense polymorphism in the human carboxypeptidase E gene alters enzymatic activity. Hum Mutat (2001) 1.21
Analysis of the palmitoylation and membrane targeting domain of neuromodulin (GAP-43) by site-specific mutagenesis. Biochemistry (1993) 1.21
Secretion of the Bordetella pertussis adenylate cyclase from Escherichia coli containing the hemolysin operon. Biochemistry (1990) 1.21
Four 5-hydroxytryptamine7 (5-HT7) receptor isoforms in human and rat produced by alternative splicing: species differences due to altered intron-exon organization. J Neurochem (1997) 1.20
The CRE/CREB pathway is transiently expressed in thalamic circuit development and contributes to refinement of retinogeniculate axons. Neuron (2001) 1.19
Determination of the free-energy coupling for binding of calcium ions and troponin I to calmodulin. Biochemistry (1982) 1.19
Type I calmodulin-sensitive adenylyl cyclase is neural specific. J Neurochem (1993) 1.18
Calcium-independent stimulation of Bordetella pertussis adenylate cyclase by calmodulin. Biochemistry (1982) 1.18
Synergistic activation of the type I adenylyl cyclase by Ca2+ and Gs-coupled receptors in vivo. J Biol Chem (1994) 1.17
Identification of the protein kinase C phosphorylation site in neuromodulin. Biochemistry (1990) 1.17
Mechanism of bacitracin action: a specific lipid-peptide interaction. Ann N Y Acad Sci (1974) 1.16
Targeted mutations that ablate either the adenylate cyclase or hemolysin function of the bifunctional cyaA toxin of Bordetella pertussis abolish virulence. Proc Natl Acad Sci U S A (1992) 1.15
Stimulation of the type III olfactory adenylyl cyclase by calcium and calmodulin. Biochemistry (1992) 1.14
China engages global health governance: processes and dilemmas. Glob Public Health (2009) 1.14
Calmodulin inhibits entry of Bordetella pertussis adenylate cyclase into animal cells. Biochemistry (1985) 1.14
1,4-Disubstituted imidazoles are potential antibacterial agents functioning as inhibitors of enoyl acyl carrier protein reductase (FabI). Bioorg Med Chem Lett (2001) 1.14
A gene conferring susceptibility to type 2 diabetes in conjunction with obesity is located on chromosome 18p11. Diabetes (2001) 1.13
Modification of adenylate cyclase activity in LM cells by manipulation of the membrane phospholipid composition in vivo. Proc Natl Acad Sci U S A (1976) 1.12
Regulation of free calmodulin levels by neuromodulin: neuron growth and regeneration. Trends Pharmacol Sci (1990) 1.12
Measurement of angiotensin II in human plasma: technical modifications and practical experience. Clin Chim Acta (1976) 1.12
Calmodulin-regulated adenylyl cyclases and neuromodulation. Curr Opin Neurobiol (1997) 1.12
Intracellular sorting of neuromodulin (GAP-43) mutants modified in the membrane targeting domain. J Neurosci (1994) 1.11
Disruption of Escherichia coli outer membranes by EM 49. A new membrane active peptide. Biochemistry (1976) 1.11
Purification and characterization of a calmodulin-sensitive adenylate cyclase from Bordetella pertussis. Biochemistry (1985) 1.10
Isolation and structure determination of Pachybasium cerebrosides which potentiate the antifungal activity of aculeacin. J Antibiot (Tokyo) (1988) 1.10
Phosphorylation and inhibition of type III adenylyl cyclase by calmodulin-dependent protein kinase II in vivo. J Biol Chem (1996) 1.10
Inactivation of the mouse adenylyl cyclase 3 gene disrupts male fertility and spermatozoon function. Mol Endocrinol (2005) 1.09
Calcium and muscarinic agonist stimulation of type I adenylylcyclase in whole cells. J Biol Chem (1992) 1.09
Enhanced hippocampal CA1 LTP but normal spatial learning in inositol 1,4,5-trisphosphate 3-kinase(A)-deficient mice. Learn Mem (1999) 1.09
Circadian regulation of mammalian target of rapamycin signaling in the mouse suprachiasmatic nucleus. Neuroscience (2011) 1.09
Upregulation of cAMP response element-mediated gene expression during experience-dependent plasticity in adult neocortex. J Neurosci (2000) 1.08
Fluorescence energy transfer analysis of calmodulin-peptide complexes. Biochemistry (1992) 1.08
Interactions between neurogranin and calmodulin in vivo. J Biol Chem (1999) 1.07